Dow Jones Venture Wire
With Drugs In Doubt, Some Biotechs Are Selling Out
- By Brian Gormely
"...Numoda now plans to develop Vitreosolve in the primary indication of vitreomacular adhesion and the secondary indication of inducing a posterior-vitreous detachment in the treatment of diabetic retinopathy. The firm plans new, placebo-controlled studies and is consulting drug-makers to find other ways to groom Vitreosolve for a sale. It aims to speed the auctioning process through technology from an affiliate, Numoda Technologies Inc., that enables potential bidders to see trial data as they are generated."
Showing posts with label numoda. Show all posts
Showing posts with label numoda. Show all posts
Numoda: What clients think
T.S., Sponsor
I am so impressed with what you are doing for this sponsor, and I asked B. to Use Numoda on his Hep C trials, because he is killing us with his paperwork.
Investigator - Liver Transplant Specialist
Could you get our other large client to have Numoda run their trials for them? It is so much easier to do a trial with Numoda - everyone remarks on it, daily. We have had so many problems and delays with the other trial - and none on this trial. Is there any way I can help?
Good morning. It works and it is WONDERFUL!!! You have saved me hours worth of work!!! Thank you and please thank anyone who campaigned for us for this!!!
Project Manager - Cardiology
Project Manager - Cardiology
I am so impressed with what you are doing for this sponsor, and I asked B. to Use Numoda on his Hep C trials, because he is killing us with his paperwork.
Investigator - Liver Transplant Specialist
Could you get our other large client to have Numoda run their trials for them? It is so much easier to do a trial with Numoda - everyone remarks on it, daily. We have had so many problems and delays with the other trial - and none on this trial. Is there any way I can help?
Subscribe to:
Posts (Atom)